Status:

COMPLETED

Diagnosis Exclusion of Recurrent Deep Vein Thrombosis of the Lower Limbs

Lead Sponsor:

Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer

Collaborating Sponsors:

Centre Hospitalier Universitaire de Saint Etienne

Investigation network on venous thrombo-embolism

Conditions:

Deep Vein Thrombosis

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

The purpose is to assess the safety of a management strategy based on colour doppler ultrasound (CDUS) and D-Dimer test results for the diagnosis exclusion of recurrent deep vein thrombosis (DVT) of t...

Detailed Description

Venous thromboembolism (VTE) recurrence is a common situation after stopping anticoagulant treatment. This recurrence requires extended anticoagulant therapy to prevent thrombosis progression and embo...

Eligibility Criteria

Inclusion

  • Age \>= 18 years
  • Known history of objectively documented deep vein thrombosis of the lower limb (with or without pulmonary embolism)
  • Out-patients referred for clinically suspected acute recurrent ipsilateral DVT of the lower limb i.e. the occurrence of new symptoms and signs of DVT or the increase of symptoms and signs in patients with post-thrombotic syndrome
  • Patients covered by social security or equivalent regimen
  • Signed and dated informed consent

Exclusion

  • Known current pregnancy
  • Any condition, which, in the opinion of the investigator may prevent him from performing the colour doppler ultrasound test (plaster cast, inaccessible vein segment after abdominal or pelvic surgery, or other causes that may lead to a technically inadequate CDUS)
  • Delay from onset of symptoms to inclusion of more than 10 days
  • Therapeutic anticoagulation for more than 48 hours in the two days prior to consent or a need for long term anticoagulation
  • Prophylactic anticoagulation for more than 48 hours in the two days prior to consent
  • Clinical symptoms of pulmonary embolism
  • Life expectancy less than 3 months
  • Patient unable to adhere to protocol or follow-up visits and contacts
  • Participants under legal guardianship or incapacitation
  • Patient already enrolled in a deep vein thrombosis (DVT) diagnostic research

Key Trial Info

Start Date :

January 17 2020

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

January 30 2023

Estimated Enrollment :

466 Patients enrolled

Trial Details

Trial ID

NCT03868956

Start Date

January 17 2020

End Date

January 30 2023

Last Update

November 20 2025

Active Locations (45)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 12 (45 locations)

1

Centre Hospitalier de Vichy

Vichy, Allier, France, 03200

2

Centre Hospitalier Universitaire de Nice

Nice, Alpes-Maritimes, France, 06001

3

Centre Hospitalier de Carcassonne

Carcassonne, Aude, France, 1060

4

Centre d'angiologie

Carcassonne, Aude, France, 11000